[ad_1] The United States Food and Drug Administration (FDA) approved topic glycopyrronium ( Qbrexza Dermira) for the treatment of adults and children as young as 9 years of age who have hyperhidrosis …
Read More »FDA Validates New Topical Treatment for Underarm Excessive Sweating
